CRISPR Therapeutics AG (NASDAQ:CRSP) Goldman Sachs 46th Annual Global Healthcare Conference June 9, 2025 3:20 PM ETCompany ParticipantsSamarth Kulkarni - ...

Genome editing technologies like CRISPR-Cas9 have transformed biology, medicine, and agriculture, but concerns remain about ...

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

But CRISPR Therapeutics CEO Sam Kulkarni is now turning the company’s attention to more common conditions; his team is testing ways to use the technology to edit genes responsible for certain cases of ...

This creates an interesting dynamic in terms of what success will look like for BC in 2025. The schedule is no cake walk, either.

This might help: The analyst community's current consensus price target of $77.21 is about 75% above this stock's present ...

A fertilized egg somehow manages to build skin, brain, and blood cells within days. But how? New tech called LoxCode is ...

Chemistry falls under the umbrella of natural sciences, alongside other fields like biology, geology and physics. Chemistry ...

When Allan Creel set out to re-enter the digital space, Fenske Media was the perfect match. The resulting acquisition showcased how two "haves" maximize value for both parties.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about ...

Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how ...